ACHV has been granted a new patent
Dec 25, 2024, 11:37 PM
-20.84%
What does ACHV do
Achieve Life Sciences, based in Seattle, is developing cytisinicline, a plant-based alkaloid, for smoking cessation and nicotine addiction, targeting cravings and withdrawal symptoms. The company employs 22 full-time staff.
ACHV filed a patent for "compositions comprising cytisine in the treatment and/or prevention of addiction in subjects in need thereof" on Wed, April 26, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.